Back to results
US 11,530,241 B2Granted
Peptides for treatment and prevention of nonalcoholic fatty liver disease and fibrosis
AssigneesUniversite De Strasbourg, Inserm (Institut National De La Sante Et De La Recherche Medicale)
InventorVincent Marion
Life of this patent
Estimating the term…
Abstract
The present invention relates to peptides for the treatment or prevention of nonalcoholic fatty liver disease (NAFLD), non-alcoholic fatty liver (NAFL), non-alcoholic steatohepatitis (NASH), hepatic steatosis (fatty liver), liver inflammation, cirrhosis, hepatocellular carcinoma or fibrosis, especially liver fibrosis.
Claims8
A peptide wherein the peptide sequence comprises
- (SEQ ID NO:
- 32)
- VECTTREKEVLASLDKAAFLTQLHS;
- wherein R and S are stapled.
1 more element
Dependencies are inferred from the claim text.